PAIR OF ACEs PROPEL MERCK, SQUIBB SALES IN 1988: ACE INHIBITORS VASOTEC AND CAPOTEN EACH REACH $1 BIL. IN GLOBAL SALES; MEVACOR APPROACHES $200 MIL. SALES

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".